DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

LEAPIND vs SICAGEN: Stock Comparison

LEAP INDIA vs SICAGEN INDIAUpdated 6 Nov 26, 4:08 PM ISTNSE & company filings

LEAP INDIA is the larger company by market capitalisation. SICAGEN INDIA shows a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

LEAPIND leads 1; SICAGEN leads 4 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

LEAPINDSICAGEN

Valuation lens

What price are you paying?

Market CapContext only
₹5,375 Cr
₹218 Cr
P/E RatioSame reading
—
11.41x
P/B RatioSame reading
—
0.47x
EPSSICAGEN has the higher reading
₹0.4
₹1.75 ✓
Book ValueContext only
—
₹125.09
Dividend YieldSICAGEN has the higher reading
0%
1.81% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
LEAPIND is the larger company
₹5,375 Cr vs ₹218 Cr
EPS
SICAGEN has higher earnings per share
₹1.75 vs ₹0.4
Dividend Yield
SICAGEN has a higher dividend yield
1.81% vs 0%
Qtr Sales Growth
LEAPIND has stronger quarterly sales growth
3.82% vs 2.9%
Qtr Profit Growth
SICAGEN has stronger quarterly profit growth
55.38% vs -28.02%
Net Margin
SICAGEN has a higher net margin
1.86% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricLEAPINDSICAGEN
Live Price₹121.97₹55.28
Day Change0.05%-3.15%
Volume26.77 L11,971
52-Week High₹172.29₹74.06
52-Week Low₹111.55₹46.55
Distance from 52W High-29.21%-25.36%

Valuation

MetricLEAPINDSICAGEN
Market Cap₹5,375 Cr₹218 Cr
P/E Ratio—11.41x
P/B Ratio—0.47x
EPS₹0.4₹1.75
Book Value—₹125.09
Dividend Yield0%1.81%

Growth

MetricLEAPINDSICAGEN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth3.82%2.9%
Qtr Profit Growth-28.02%55.38%

Profitability & Leverage

MetricLEAPINDSICAGEN
ROE—3.65%
ROCE—4.43%
Net Margin0%1.86%
Operating Margin—3.9%
Debt to Equity—0.29x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricLEAPINDSICAGEN
Promoter Holding20.53%23.92%
FII Holding19.27%▲ 4.03 pp2.47%
DII Holding9.18%▼ 0.83 pp0.58%
Public Holding15.92%▼ 3.19 pp35.81%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: LEAP INDIA and SICAGEN INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.